Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. Chen Lab - Home. Welcome to the Chen Lab website! Announcements. April 24, 2024. Congrats to Ximin, Laurence, and Amy for the publication in Nature Metabolism! April 12, 2024. Congrats to Meng-Yin, Chris, Ryan, and team for the publication in Journal of Experimental Medicine! April 1, 2024.

    • Team

      Yvonne is also the co-director of the Tumor Immunology and...

    • Research

      Our focus is on mammalian systems, particularly in...

    • Publications

      Advances in promoting chimeric antigen receptor T cell...

  2. Dr. Yvonne Chen's research focuses on applying molecular and synthetic biology techniques to rewire and construct novel biological circuits for applications in health and medicine, particularly in cell-based immunotherapy.

  3. 15 giu 2023 · Meet Yvonne Chen, PhD, who designs novel strategies to make CAR-T cell immunotherapies safer and more effective for cancer treatment.

  4. 2020. Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems. YY Chen, MC Jensen, CD Smolke. Proceedings of the National Academy of Sciences 107 (19), 8531-8536. , 2010. 316. 2010. Navigating CAR-T cells through the solid-tumour microenvironment. AJ Hou, LC Chen, YY Chen.

  5. Chen X, Chen LC, Khericha M, Meng X, Salvestrini E, Shafer A, Iyer N, Alag AS, Ding Y, Nicolaou DM, Chen YY. PMID: 36409926; PMCID: PMC9898126. View in: PubMed Mentions: 2 Fields: All Allergy and Immunology Neo Neoplasms. The sound of silence: Transgene silencing in mammalian cell engineering.

  6. The adoptive transfer of T cells that are engineered to express chimeric antigen receptors (CARs) has shown remarkable success in treating B cell malignancies but only limited efficacy against other cancer types, especially solid tumours.

  7. Yvonne Chen, Ph.D., applies biomolecular engineering and synthetic biology principles to advance the development of next-generation adoptive CAR-T cell therapies for cancer. She seeks to enhance the safety, efficacy and applicability of these immunotherapy approaches across a wide range of cancer types. Adoptive T-cell immunotherapy is the ...